James Hodge
Overview
Explore the profile of James Hodge including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
79
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Yiangou K, Mavaddat N, Dennis J, Zanti M, Wang Q, Bolla M, et al.
Breast Cancer Res
. 2024 Dec;
26(1):189.
PMID: 39734228
Background: The 313-variant polygenic risk score (PRS) provides a promising tool for clinical breast cancer risk prediction. However, evaluation of the PRS across different European populations which could influence risk...
2.
Huang H, Couch R, Karam R, Hu C, Boddicker N, Polley E, et al.
Clin Cancer Res
. 2024 Nov;
31(1):130-138.
PMID: 39513960
Purpose: To determine the relationship between germline pathogenic variants (PV) in cancer predisposition genes and the risk of ductal carcinoma in situ (DCIS). Experimental Design: Germline PV frequencies in breast...
3.
Yiangou K, Mavaddat N, Dennis J, Zanti M, Wang Q, Bolla M, et al.
medRxiv
. 2024 Feb;
PMID: 38410445
The 313-variant polygenic risk score (PRS) provides a promising tool for breast cancer risk prediction. However, evaluation of the PRS across different European populations which could influence risk estimation has...
4.
Rees-Punia E, Deubler E, Patel A, Diver W, Hodge J, Islami F, et al.
AJPM Focus
. 2023 Oct;
1(1):100013.
PMID: 37791015
Introduction: The role of individual risk factors in the rural‒urban mortality disparity is poorly understood. The purpose of this study was to explore the role of individual-level demographics and health...
5.
Stolarova L, Kleiblova P, Zemankova P, Stastna B, Janatova M, Soukupova J, et al.
Clin Cancer Res
. 2023 Jul;
29(16):3037-3050.
PMID: 37449874
Purpose: Germline pathogenic variants in CHEK2 confer moderately elevated breast cancer risk (odds ratio, OR ∼ 2.5), qualifying carriers for enhanced breast cancer screening. Besides pathogenic variants, dozens of missense...
6.
Amgad M, Hodge J, Elsebaie M, Bodelon C, Puvanesarajah S, Gutman D, et al.
Res Sq
. 2023 Jun;
PMID: 37293118
Breast cancer is a heterogeneous disease with variable survival outcomes. Pathologists grade the microscopic appearance of breast tissue using the Nottingham criteria, which is qualitative and does not account for...
7.
Lee M, Robbins Y, Sievers C, Friedman J, Sater H, Clavijo P, et al.
J Immunother Cancer
. 2021 Mar;
9(3).
PMID: 33741731
Background: As heterogeneous tumors develop in the face of intact immunity, tumor cells harboring genomic or expression defects that favor evasion from T-cell detection or elimination are selected. For patients...
8.
Hodge J, Foley S, Brankaert R, Kenning G, Lazar A, Boger J, et al.
Proc SIGCHI Conf Hum Factor Comput Syst
. 2020 Jul;
2020.
PMID: 32705092
Engaging in participatory research in HCI raises numerous ethical complexities such as consent, researcher relationships, and participant compensation. Doing HCI work in the area of dementia amplifies these issues, and...
9.
Dignam T, Hodge J, Chuke S, Mercado C, Ettinger A, Flanders W
Environ Epidemiol
. 2020 Jul;
4(2).
PMID: 32607462
Background: Local, state, and national childhood blood lead surveillance is based on healthcare providers and clinical laboratories reporting test results to public health departments. Increased interest in detecting blood lead...
10.
Friedman J, Padget M, Lee J, Schlom J, Hodge J, Allen C
Oral Oncol
. 2019 Mar;
90:38-44.
PMID: 30846174
High affinity natural killer cells (haNKs) are a cell therapy product capable of mediating both direct and antibody-dependent cell-mediated cytotoxicity (ADCC). These cells may be particularly useful in tumors that...